7Baggers
 Cantor Fitzgerald maintains Overweight rating on Taysha Gene Therapies stock  Investing.com Canada Fri, 14 Nov 2025 23:21:01 GMT
 published on: 2025-11-09 05:46:32  newser.com Sun, 09 Nov 2025 11:46:32 GMT
 Citizens Lifts Price Target for Taysha Gene Therapies (TSHA)  Insider Monkey Sat, 08 Nov 2025 02:45:12 GMT
 taysha gene therapies hits day low at $3.97 amid price pressure  Markets Mojo Sat, 08 Nov 2025 00:47:10 GMT
 Citizens Lifts Price Target for Taysha Gene Therapies (TSHA)  Yahoo Finance Fri, 07 Nov 2025 08:00:00 GMT
 taysha gene therapies hits day low at $3.97 amid price pressure  Markets Mojo Thu, 06 Nov 2025 08:59:18 GMT
 taysha gene therapies stock price target raised to $8 at citizens  Investing.com Nigeria Thu, 06 Nov 2025 03:11:53 GMT
 taysha gene therapies (tsha) maintains "buy" rating at $12 by ch  GuruFocus Thu, 06 Nov 2025 01:46:28 GMT
 Taysha Gene Therapies (TSHA) Maintains "Buy" Rating at $12 by Ch  GuruFocus Wed, 05 Nov 2025 21:23:02 GMT
 taysha gene therapies is maintained at market outperform by citizens  富途牛牛 Wed, 05 Nov 2025 13:32:10 GMT
 taysha gene therapies stock price target raised to $8 at citizens  Investing.com UK Wed, 05 Nov 2025 11:00:00 GMT
 Citizens Maintains Taysha Gene Therapies (TSHA) with Raised Pric  GuruFocus Wed, 05 Nov 2025 08:00:00 GMT
 taysha gene therapies advances tsha-102 program  TipRanks Wed, 05 Nov 2025 05:52:27 GMT
 Decoding Taysha Gene Therapies Inc (TSHA): A Strategic SWOT Insi  GuruFocus Wed, 05 Nov 2025 05:37:54 GMT
 taysha gene therapies q3 2025 earnings call transcript  MarketBeat Wed, 05 Nov 2025 02:23:49 GMT
 taysha gene therapies q3 2025 earnings call transcript  MarketBeat Tue, 04 Nov 2025 15:56:15 GMT
 taysha gene therapies q3 net loss narrows  MarketScreener Tue, 04 Nov 2025 13:49:18 GMT
 taysha (tsha) financial outlook: cash reserves to support operat  GuruFocus Tue, 04 Nov 2025 12:57:23 GMT
 taysha gene therapies reports q3 eps (9c), consensus (9c)  TipRanks Tue, 04 Nov 2025 12:40:34 GMT
 taysha gene therapies q3 net loss widens as r&d costs rise  MarketScreener Tue, 04 Nov 2025 12:25:49 GMT
 Taysha Gene Therapies Advances TSHA-102 Program  TipRanks Tue, 04 Nov 2025 08:00:00 GMT
 Taysha Gene Therapies Amends Sales Agreement, Expands Offering  TipRanks Tue, 04 Nov 2025 08:00:00 GMT
 What To Expect From Taysha Gene Therapies Inc (TSHA) Q3 2025 Earnings  Yahoo Finance Mon, 03 Nov 2025 08:00:00 GMT
 will breakout in taysha gene therapies inc. lead to full recovery  newser.com Sat, 01 Nov 2025 09:20:37 GMT

Taysha Gene Therapies, Inc
(NASDAQ:TSHA) 

TSHA stock logo

Taysha Gene Therapies, Inc., a gene therapy company, focuses on developing and commercializing adeno-associated virus-based gene therapies for the treatment of monogenic diseases of the central nervous system. It primarily develops TSHA-101 for the treatment of GM2 gangliosidosis; TSHA-118 for the t...

Founded: 2019
CEO: R. A. Session  
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends